Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes

被引：23
|
作者：
Akturk, Halis Kaan [1 ]
Rewers, Amanda [1 ]
Joseph, Hal [1 ]
Schneider, Nicole [1 ]
Garg, Satish K. [1 ]
机构：
[1] Univ Colorado, Barbara Davis Ctr Diabet Adult Clin, 1775 Aurora Court,A140, Aurora, CO 80045 USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
Type; 1; diabetes; Postprandial blood glucose; Insulin; Technosphere insulin; Postprandial glucose excursions; Fast-acting insulin; FIasp; BioChaperone insulin; STAT study; Hyperglycemia; Pramlintide; GLP-1; analog; Inhaled insulin; ACTING INSULIN ASPART; DAFNE STRUCTURED EDUCATION; TREAT-TO-TARGET; GLYCEMIC CONTROL; PLASMA-GLUCOSE; CARDIOVASCULAR-DISEASE; INHALED INSULIN; TECHNOSPHERE INSULIN; DIETARY-PROTEIN; DOSE ADJUSTMENT;
D O I：
10.1089/dia.2018.0114
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：24 / 32
页数：9
相关论文
共 50 条
  • [41] Postprandial metabolic effects of fructose and glucose in type 1 diabetes patients: a pilot randomized crossover clinical trial
    Souto, Debora Lopes
    Lima, Erika dos Santos
    Dantas, Joana Rodrigues
    Zajdenverg, Lenita
    Rodacki, Melanie
    Rosado, Eliane Lopes
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2019, 63 (04): : 376 - 384
  • [42] A proposal for breakfast to improve the postprandial glucose response in children with type 1 diabetes - Preliminary results from a camp-based study
    Marino, Monica
    Boccolini, Giada
    Tombolini, Patrizio
    Tiberi, Valentina
    Iannilli, Antonio
    Santarelli, Sara
    Gasparini, Francesco
    Carciofi, Annalisa
    Capogna, Antonia
    Cherubini, Valentino
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 218
  • [43] Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial
    Ledesma, Gilbert
    Umpierrez, Guillermo E.
    Morley, John E.
    Lewis-D'Agostino, Diane
    Keller, Annett
    Meinicke, Thomas
    van der Walt, Sandra
    von Eynatten, Maximilian
    DIABETES OBESITY & METABOLISM, 2019, 21 (11) : 2465 - 2473
  • [44] Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
    Akturk, Halis Kaan
    Snell-Bergeon, Janet K.
    Rewers, Amanda
    Klaff, Leslie J.
    Bode, Bruce W.
    Peters, Anne L.
    Bailey, Timothy S.
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) : 639 - 647
  • [45] Harnessing the incretin system beyond glucose control: Potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes
    Cariou, B.
    DIABETES & METABOLISM, 2012, 38 (04) : 298 - 308
  • [46] Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
    Tremblay, A. J.
    Lamarche, B.
    Deacon, C. F.
    Weisnagel, S. J.
    Couture, P.
    DIABETES OBESITY & METABOLISM, 2011, 13 (04) : 366 - 373
  • [47] Can inhaled insulin improve glycemic control of type 2 diabetes?
    Pendergrass, M
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (06): : 308 - 309
  • [48] Glycemic Management Around Postprandial Exercise in People With Type 1 Diabetes: Challenge Accepted
    Helleputte, Simon
    Stautemas, Jan
    Jansseune, Laura
    De Backer, Tine
    Marlier, Joke
    Lapauw, Bruno
    Calders, Patrick
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (08) : 2039 - 2052
  • [49] Prediction of postprandial glucose excursions in type 1 diabetes using control-oriented process models
    Adelberger, D.
    Reiterer, F.
    Schrangl, P.
    Ringemann, Ch
    Huschto, T.
    del Re, L.
    IFAC PAPERSONLINE, 2021, 54 (15): : 466 - 471
  • [50] Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomized crossover trial
    Garcia, Alia
    Moscardo, Vanessa
    Ramos-Prol, Agustin
    Diaz, Julian
    Boronat, Miguel
    Bondia, Jorge
    Rossetti, Paolo
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
12345